Patent US4602014A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4602014A Expired / Lapsed US ⏱️ 0.0 years remaining

Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators

Assignee: Novartis Corp
•
Filing: 1985-06-19
•
Granted: 1986-07-22
•
Expires: 2005-06-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula formula IA or IB ##STR1## wherein A represents an optionally substituted saturated divalent grouping which together with the two carbon atoms to which it is attached represents a fused 5-, 6- or 7-membered carbocyclic or heterocyclic ring selected from optionally substituted fused cyclopenteno, cyclohexeno, cyclohepteno, dihydrothieno, dihydrothiopyrano, tetrahydrothiepino, dihydrofuro, dihydropyrano, tetrahydrooxepino, dihydropyrrolo, tetrahydropyrido and tetrahydroazepino; R 1 represents lower alkyl, phenyl, or phenyl mono- or disubstituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from e.g. optionally substituted pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl; R 2 , R 3 , R 3 ' are hydrogen or lower alkyl; and pharmaceutically acceptable salts; are useful as benzodiazepine receptor modulators for the treatment of nervous system disorders. Pharmaceutical compositions, methods of preparation and certain intermediates useful as benzodiazepine receptor modulators are also disclosed.

Inventors

  • 👤 Naokata Yokoyama

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 10:31
CPC Classifications
C; C07; C07D; C07D221/00; C07D221/02; C07D221/04; C07D207/00; C07D207/02; C07D207/18; C07D207/22; C07D215/00; C07D215/02; C07D215/16; C07D215/48; C07D215/54; C07D215/56; C07D401/00; C07D401/02; C07D401/12; C07D471/00; C07D471/02; C07D471/04; C07D471/12; C07D471/14; C07D493/00; C07D493/02; C07D493/04; C07D493/12; C07D493/14; C07D495/00; C07D495/02; C07D495/04; C07D495/12; C07D495/14

Claims Analysis

Total Claims: 34
Claim 1
Independent Claim 278 words
A compound of the formula ##STR28## wherein A together with the two carbon atoms to which it is attached represents a fused 5-, 6- or 7-membered carbocyclic or heterocyclic ring selected from (a) cyclopenteno, cyclohexeno and cyclohepteno; each unsubstituted or mono- or di-substituted or carbon atoms within A by lower alkyl, hydroxy, lower alkanoyloxy, aroyloxy, oxo, lower alkoxy, aryl, aryl-lower alkyl or aryl-lower alkoxy; (b) dihydrothieno, dihydrothiopyrano and tetrahydrothiepino; each unsubstituted or mono- or di-substituted on carbon atoms within A by lower alkyl, lower alkoxycarbonyl, aryl or aryl-lower alkyl; or the S-mono- or di-oxo derivative of any said ring; (c) dihyrofuro, dihydropyrano, and tetrahydrooxepino; each unsubstituted or mono- or disubstituted on carbon atoms within A by lower alkyl, lower alkoxycarbonyl, aryl or aryl-lower alkyl; (d) dihydropyrrolo, tetrahydropyrido and tetrahydroazepino; each unsubstituted, or substituted on nitrogen by lower alkoxycarbonyl, carbamoyl, mono- or di-lower alkylcarbamoyl, monoarylcarbamoyl, lower alkyl, aryl-lower alkyl, lower alkanoyl, aroyl or aryl-lower alkanoyl; each unsubstituted or mono- or disubstituted on carbon atoms within A by lower alkyl, oxo, aryl or aryl-lower alkyl; R 1 represents lower alkyl, phenyl, or phenyl substituted by one or two radicals selected from lower alkyl, lower alkoxy, halogen and trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said heterocyclic aromatic radical mono- or di-substituted by lower alkyl, lower alkoxy or halogen; R 2 , R 3 and R 3 ' independently represent hydrogen or lower alkyl; and the term aryl within any of the above definitions represents phenyl or phenyl mono- or disubstituted by lower alkyl, lower alkoxy, hydroxy, lower alkanoyloxy, aroyloxy, halogen or trifluoromethyl; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 278 words
A compound of the formula ##STR28## wherein A together with the two carbon atoms to which it is attached represents a fused 5-, 6- or 7-membered carbocyclic or heterocyclic ring selected from (a) cyclopenteno, cyclohexeno and cyclohepteno; each unsubstituted or mono- or di-substituted or carbon atoms within A by lower alkyl, hydroxy, lower alkanoyloxy, aroyloxy, oxo, lower alkoxy, aryl, aryl-lower alkyl or aryl-lower alkoxy; (b) dihydrothieno, dihydrothiopyrano and tetrahydrothiepino; each unsubstituted or mono- or di-substituted on carbon atoms within A by lower alkyl, lower alkoxycarbonyl, aryl or aryl-lower alkyl; or the S-mono- or di-oxo derivative of any said ring; (c) dihyrofuro, dihydropyrano, and tetrahydrooxepino; each unsubstituted or mono- or disubstituted on carbon atoms within A by lower alkyl, lower alkoxycarbonyl, aryl or aryl-lower alkyl; (d) dihydropyrrolo, tetrahydropyrido and tetrahydroazepino; each unsubstituted, or substituted on nitrogen by lower alkoxycarbonyl, carbamoyl, mono- or di-lower alkylcarbamoyl, monoarylcarbamoyl, lower alkyl, aryl-lower alkyl, lower alkanoyl, aroyl or aryl-lower alkanoyl; each unsubstituted or mono- or disubstituted on carbon atoms within A by lower alkyl, oxo, aryl or aryl-lower alkyl; R 1 represents lower alkyl, phenyl, or phenyl substituted by one or two radicals selected from lower alkyl, lower alkoxy, halogen and trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said heterocyclic aromatic radical mono- or di-substituted by lower alkyl, lower alkoxy or halogen; R 2 , R 3 and R 3 ' independently represent hydrogen or lower alkyl; and the term aryl within any of the above definitions represents phenyl or phenyl mono- or disubstituted by lower alkyl, lower alkoxy, hydroxy, lower alkanoyloxy, aroyloxy, halogen or trifluoromethyl; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 221 words
A compound according to claim 1 of formula IA or IB wherein A together with the two carbon atoms to which it is attached represents a fused ring selected from (a) cyclopenteno, cyclohexeno and cyclohepteno in which A represents propylene, butylene or pentylene respectively; each unsubstituted or mono- or di-substituted on carbon atoms within A by lower alkyl, hydroxy, lower alkanoyloxy, aroyloxy, oxo, lower alkoxy, aryl, aryl-lower alkyl or aryl-lower alkoxy; (b) dihydro(-3,4-,-2,3- or -3,2-)thieno, dihydro(-3,4- or -4,3-)thiopyrano, tetrahydro(-4,5-, -4,3- or -3,4-)thiepino; each ring unsubstituted or mono- or di-substituted on carbon atoms within A by lower alkyl, lower alkoxycarbonyl, aryl or aryl-lower alkyl; or the S-mono- or di-oxo derivative thereof; (c) dihydro-3,4-furo, dihydro(-3,4- or -4,3-)pyrano, tetrahydro(-4,5-, -4,3- or -3,4-)oxepino; each ring unsubstituted or mono- or di-substituted on carbon atoms within A by lower alkyl, lower alkoxycarbonyl, aryl or aryl-lower alkyl; (d) dihydro-3,4-pyrrolo, tetrahydro(-3,4- or -4,3-)pyrido, tetrahydro(-4,5-, -4,3- or -3,4-)azepino; each ring unsubstituted or substituted on nitrogen by lower alkyl, lower alkoxycarbonyl, carbamoyl, mono- or di-lower alkylcarbamoyl, monoarylcarbamoyl, lower alkyl, aryl-lower alkyl, lower alkanoyl, aroyl or aryl-lower alkanoyl; or said ring mono- or disubstituted on carbon atoms within A by lower alkyl, aryl or aryl-lower alkyl; R 1 , R 2 , R 3 , R 3 ' and aryl have meaning as in claim 1; or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 97 words
A compound according to claim 2 of the formula II ##STR29## wherein R o represents hydrogen, lower alkyl, aryl-lower alkyl, monoarylcarbamoyl, lower alkanoyl or lower alkoxycarbonyl; R 1 represents lower alkyl, phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said radical mono- or disubstituted by lower alkyl, lower alkoxy or halogen; R 4 and R 5 represent independently hydrogen, lower alkyl, or aryl-lower alkyl; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 101 words
A compound according to claim 2 of the formula III ##STR30## wherein R 1 represents lower alkyl, phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said radical mono- or disubstituted by lower alkyl, lower alkoxy or halogen; R 6 and R 7 represent independently hydrogen, lower alkyl, hydroxy, lower alkanoyloxy, aroyloxy, lower alkoxy, phenyl or phenyl mono- or disubstituted by lower alkyl, lower alkoxy, hydroxy, halogen or trifluoromethyl; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim 101 words
A compound according to claim 2 of the formula ##STR31## wherein R 1 represents lower alkyl, phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said radical mono- or disubstituted by lower alkyl, lower alkoxy or halogen; R 6 ' and R 7 ' represent independently hydrogen, lower alkyl, hydroxy, lower alkanoyloxy, aroyloxy, lower alkoxy, phenyl or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim 93 words
A compound according to claim 2 of formula V ##STR32## wherein R 1 represents lower alkyl, phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said heterocyclic radical mono- or disubstituted by lower alkyl, lower alkoxy or halogen; R 8 represents hydrogen, lower alkyl, hydroxy, lower alkanoyloxy, aroyloxy, lower alkoxy, phenyl or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 91 words
A compound according to claim 2 of the formula VI ##STR33## wherein n represents 0, 1 or 2; R 1 represents lower alkyl, phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said radical mono- or disubstituted by lower alkyl, lower alkoxy or halogen; R 9 and R 10 represent independently hydrogen, lower alkyl, lower alkoxycarbonyl or aryl-lower alkyl; or a tautomer thereof; a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 85 words
A compound according to claim 2 of the formula VII ##STR34## wherein R 1 represents lower alkyl, phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said radical mono- or disubstituted by lower alkyl, lower alkoxy or halogen; R 11 and R 12 represent independently hydrogen, lower alkyl, lower alkoxycarbonyl or aryl-lower alkyl; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim 87 words
A compound according to claim 2 of the formula ##STR35## wherein n represents 0, 1 or 2; R 1 represents lower alkyl, phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said radical mono- or disubstituted by lower alkyl, lower alkoxy or halogen; R 9 a represents hydrogen, lower alkyl, lower alkoxycarbonyl or aryl-lower alkyl; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim 35 words
A compound of claim 9 wherein n represents zero; R 1 represents phenyl, or phenyl monosubstituted by lower alkoxy or halogen; R 9 a is hydrogen; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim 87 words
A compound according to claim 2 of the formula ##STR36## wherein n represents 0, 1 or 2; R 1 represents lower alkyl, phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R 1 represents an aromatic heterocyclic radical selected from pyridyl, quinolyl, isoquinolyl, pyrimidyl and thiazolyl, or any said radical mono- or disubstituted by lower alkyl, lower alkoxy or halogen; R 9 b represents hydrogen, lower alkyl, lower alkoxycarbonyl or aryl-lower alkyl; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 13
Dependent Claim 35 words
A compound of claim 11 wherein n represents zero; R 1 represents phenyl, or phenyl monosubstituted by lower alkoxy or halogen; R 9 b is hydrogen; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 14
Dependent Claim 44 words
A compound of claim 3 wherein R 1 represents phenyl, or phenyl mono- or disubstituted by lower alkyl, lower alkoxy, halogen or trifluoroethyl; R o represents lower alkoxycarbonyl; R 4 and R 5 represent hydrogen; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 15
Dependent Claim 44 words
A compound of claim 4 wherein R 1 represents phenyl, or phenyl mono- or disubstituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; R 6 represents hydrogen; R 7 represents hydrogen, lower alkyl or phenyl; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 16
Dependent Claim 34 words
A compound of claim 14 and formula III wherein R 1 represents phenyl, or phenyl mono-substituted by lower alkoxy or halogen; R 6 and R 7 represent hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 17
Dependent Claim 41 words
A compound of claim 5 wherein R 1 represents phenyl, or phenyl mono- or disubstituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; R 6 ' and R 7 ' represent hydrogen; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 18
Dependent Claim 36 words
A compound of claim 6 wherein R 1 represents phenyl, or phenyl mono- or disubstituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; R 8 represents hydrogen; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 19
Dependent Claim 34 words
A compound of claim 17 and formula V wherein R 1 represents phenyl, or phenyl monosubstituted by halogen or lower alkoxy; R 8 represents hydrogen; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 20
Dependent Claim 45 words
A compound of claim 7 wherein R 1 represents phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; n represents 0, 1 or 2; R 9 and R 10 represent hydrogen; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 21
Dependent Claim 39 words
A compound of claim 8 wherein R 1 represents phenyl, or phenyl mono- or di-substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; R 11 and R 12 represent hydrogen; a tautomer thereof; or a pharmaceutically acceptable salt thereof.
Claim 22
Dependent Claim 14 words
A compound according to claim 7 being 2-p-chlorophenyl-2,3,5,6,7,9-hexahydrothiopyrano[4,3-b]pyrazolo[3,4-d]pyridin-3-one or a pharmaceutically acceptable salt thereof.
Claim 23
Dependent Claim 14 words
A compound according to claim 8 being 2-p-chlorophenyl-2,3,5,6,7,9-hexahydropyrano[4,3-b]pyrazolo[3,4-d]pyridin-3-one or a pharmaceutically acceptable salt thereof.
Claim 24
Dependent Claim 14 words
A compound according to claim 3 being 8-ethoxycarbonyl-2-p-chlorophenyl-2,3,6,7,8,9-hexahydropyrazolo[4,3-c][1,6]naphthyridin-3(5H)-one or a pharmaceutically acceptable salt thereof.
Claim 25
Dependent Claim 14 words
A compound according to claim 7 being 2-p-chlorophenyl-8,8-dioxo-2,3,5,6,7,9-hexahydrothiopyrano[4,3-b]pyrazolo[3,4-d]pyridin-3-one or a pharmaceutically acceptable salt thereof.
Claim 26
Dependent Claim 14 words
A compound according to claim 6 being 2-p-chlorophenyl-2,3,5,6,7,8-hexahydrocyclopenta[b]pyrazolo[3,4-d]pyridin-3-one or a pharmaceutically acceptable salt thereof.
Claim 27
Dependent Claim 14 words
A compound according to claim 6 being 2-phenyl-2,3,5,6,7,8-hexahydrocyclopenta[b]pyrazolo[3,4-d]pyridin-3-one or a pharmaceutically acceptable salt thereof.
Claim 28
Dependent Claim 14 words
A compound according to claim 4 being 2-p-methoxyphenyl-2,3,6,7,8,9-hexahydropyrazolo[4,3-c]quinolin-3(5H)-one or a pharmaceutically acceptable salt thereof.
Claim 29
Dependent Claim 14 words
A compound according to claim 4 being 2-p-chlorophenyl-2,3,6,7,8,9-hexahydropyrazolo[4,3-c]quinolin-3(5H)-one or a pharmaceutically acceptable salt thereof.
Claim 30
Dependent Claim 14 words
A compound according to claim 4 being 2-p-chlorophenyl-2,3,6,7,8,9-hexahydro-8-methylpyrazolo[4,3-c]quinolin-3(5H)-one or a pharmaceutically acceptable salt thereof.
Claim 31
Dependent Claim 14 words
A compound according to claim 5 being 2-p-chlorophenyl-2,3,5,6,7,8,9,10-octahydrocyclohepta[b]pyrazolo[3,4-d]pyridin-3-one or a pharmaceutically acceptable salt thereof.
Claim 32
Dependent Claim 46 words
A pharmaceutical composition, suitable for oral or parenteral administration to mammals for the treatment of nervous system conditions responsive to the action of a benzodiazepine receptor modulator, comprising an effective amount of a compound of claim 1 in combination with one or more pharmaceutically acceptable carriers.
Claim 33
Dependent Claim 52 words
A method for treating nervous system diseases responsive to benzodiazepine receptor modulation in mammals which comprises administering to a mammal in need thereof an effective amount of a compound of claim 1 or a pharmaceutical composition comprising an effective amount of said compound in combination with one or more pharmaceutically acceptable carriers.
Claim 34
Dependent Claim 47 words
A method of treating anxiety in mammals which comprises administering to a mammal in need thereof an effective amount of a compound of claim 28 or of a pharmaceutical composition comprising an effective amount of a said compound in combination with one or more pharmaceutically acceptable carriers.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-07-21 1990-01-20 1990-07-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-07-21 1994-01-20 1994-07-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-07-21 1998-01-20 1998-07-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag